Clin2
NCT07030101Possibly a fitNot yet recruiting

Study of a new medicine for high blood pressure that doesn't respond to current treatment

Hypertension

Part of Heart & circulation clinical trials.

This study tests a new medicine (called TCA108) to see if it can lower blood pressure better in people whose blood pressure is still high even when they take two other blood pressure medicines. If you qualify, you might get the new medicine or a placebo (a pill with no active ingredient) added to your current treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
400 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years old or older.
  • You must have high blood pressure (usually above 140/90) despite taking two blood pressure medicines.
  • You must be on a stable dose of two blood pressure medicines for at least 4 weeks before the study starts.
  • You must not have had a heart attack, stroke, or heart failure in the past 6 months.
  • You must not be pregnant or planning to become pregnant, and if you can have children, you must use effective birth control.
  • You must be able to attend study visits and follow the study rules.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07758634Recruiting· Phase 1/Phase 2
Study of an experimental treatment for high blood pressure

This trial tests a new treatment called CTX340 for high blood pressure that is hard to control even with multiple medications. The study aims to see if it is safe and effective.

Port Orange, Florida
NCT07833098Not yet recruiting· Phase 2
A new medicine for hard-to-control high blood pressure

This study tests a new investigational medicine called VB19055 for people whose high blood pressure is not controlled even though they are already taking multiple blood pressure medications. The trial aims to see if this new drug can help lower blood pressure more effectively.

Baotou
NCT07609875Not yet recruiting· Phase 1
Testing a new blood pressure medicine in healthy and mildly hypertensive people

This early-stage trial tests a new oral medication (HS-10522) to see if it is safe and how the body handles it. It includes both healthy people and those with mild high blood pressure, and may help lower blood pressure in the future.

NCT07660796Not yet recruiting· Phase 3
Blood pressure medication study for high blood pressure

This study tests a new blood pressure medication to see if it is safe and effective for people with high blood pressure. It may help lower your blood pressure and reduce health risks.

Goyang-si, Gyeonggi-do
NCT07465549Recruiting
A smarter way to manage hard-to-control high blood pressure

This trial uses a special blood pressure monitor (CART BP Pro) to help guide treatment for people whose blood pressure stays high despite standard care. You may qualify if your blood pressure is still too high even with medication.

Ansan
NCT07259733Recruiting
Fast control of tough high blood pressure in public clinics

This study tests a fast way to get high blood pressure under control faster for people whose current pills aren't working well enough. It focuses on people who have trouble taking all their medicine as directed (like missing doses).

São Paulo, São Paulo

Hear when a new High blood pressure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.